Cultivated by Organicsio | Verified Genotype: CQ-77

Cissus quadrangularis (Asthisamharaka / Hadjod)

The Organicsio Advantage

Organicsio employs a specialized clonal propagation protocol for Cissus quadrangularis to ensure high genetic uniformity. Unlike wild-harvested variants which often suffer from variable phytosterol content, our cultivation sites in semi-arid Indian zones utilize drip-fertigation to optimize the concentration of Ketosterones. All batches are subjected to rigorous High-Performance Thin-Layer Chromatography (HPTLC) to verify a minimum of 2.5% to 5% Ketosterone content while maintaining heavy metals strictly within global pharmacopeial limits.

Botanical Morphology & Raw Material

Dried Stock Standardized Dried Stem Cut
Botanical Drawing Internodal Segment Reference

Phytochemical Profile

The therapeutic efficacy of the Organicsio CQ-77 strain is driven by a complex matrix of lipophilic and hydrophilic constituents. Primary bioactive analysis reveals high concentrations of 3-ketosteroids (implicated in glucocorticoid antagonism) and Friedelin. Secondary metabolites include Resveratrol derivatives, Quadrangularins (A, B, C), and significant Ascorbic Acid levels, acting synergistically to stimulate osteoblast proliferation and collagen synthesis.

Commercial Applications

  • Orthopedic Formulations: Accelerated fracture healing and osteoporosis management supplements.
  • Sports Nutrition: Joint recovery matrices and connective tissue support for high-impact athletes.
  • Metabolic Management: Weight management formulations utilizing lipase-inhibiting properties.